These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 17316345)

  • 21. Cancer in the elderly: a societal perspective from the United States.
    Muss HB
    Clin Oncol (R Coll Radiol); 2009 Mar; 21(2):92-8. PubMed ID: 19059768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triple-negative breast cancer.
    Stockmans G; Deraedt K; Wildiers H; Moerman P; Paridaens R
    Curr Opin Oncol; 2008 Nov; 20(6):614-20. PubMed ID: 18841042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Training the urologic oncologist of the future: where are the challenges?
    Buscarini M; Stein JP
    Urol Oncol; 2009; 27(2):193-8. PubMed ID: 19285233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Conclusion.
    Bunn PA; Thatcher N
    Oncologist; 2008; 13 Suppl 1():37-46. PubMed ID: 18263773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New targeted therapies for non-small-cell lung cancer: a focus on the epidermal growth factor receptor.
    Crawford J
    J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S78-86. PubMed ID: 19795580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recommended core curriculum for the specialist training in surgical oncology within Europe.
    Naredi P; Leidenius M; Hocevar M; Roelofesen F; van de Velde C; Audisio RA
    Surg Oncol; 2008 Dec; 17(4):271-5. PubMed ID: 18640830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted agents in the treatment of pancreatic cancer: history and lessons learned.
    Bendell J; Goldberg RM
    Curr Opin Oncol; 2007 Jul; 19(4):390-5. PubMed ID: 17545806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The burden of scientific progress: growing inequalities in the delivery of cancer care.
    Mano M
    Acta Oncol; 2006; 45(1):84-6. PubMed ID: 16464800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ensemble methods for classification of patients for personalized medicine with high-dimensional data.
    Moon H; Ahn H; Kodell RL; Baek S; Lin CJ; Chen JJ
    Artif Intell Med; 2007 Nov; 41(3):197-207. PubMed ID: 17719213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Need for a paradigm shift in cancer prevention and clinical oncology.
    Ebert MP; Schmid R; Röcken C
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1363-7. PubMed ID: 17944562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current aspects of oncology in Lausanne].
    Cerottini JC
    Rev Med Suisse Romande; 1993 Jan; 113(1):7-8. PubMed ID: 8434222
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cancer therapy is still dominated by surgery. It will be a long time before vaccines and new drugs are available].
    Naredi P
    Lakartidningen; 1999 Sep; 96(35):3636-7. PubMed ID: 10492564
    [No Abstract]   [Full Text] [Related]  

  • 33. Why do oncologists need this new journal?
    von Roenn J
    J Support Oncol; 2003; 1(1):7-8. PubMed ID: 15352638
    [No Abstract]   [Full Text] [Related]  

  • 34. Cancer Imaging Training in the 21st Century: An Overview of Where We Are, and Where We Need To Be.
    Howard SA; Krajewski KM; Weissman BN; Seltzer SE; Ramaiya NH; Van den Abbeele AD
    J Am Coll Radiol; 2015 Jul; 12(7):714-20. PubMed ID: 26143565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Professionalism in global, personalized cancer care: restoring authenticity and integrity.
    Surbone A
    Am Soc Clin Oncol Educ Book; 2013; ():152-6. PubMed ID: 23714485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical cancer research: an embattled species.
    Frei E
    Cancer; 1982 Nov; 50(10):1979-92. PubMed ID: 7127245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [PERSONALIZED MEDICINE IN ONCOLOGY REQUIRES TEAMWORK BETWEEN MEDICAL ONCOLOGISTS AND MOLECULAR PATHOLOGISTS].
    Siegelmann-Danieli N; Mamrut S; Yehuda-Shnaidman E; Sandbank J
    Harefuah; 2022 Apr; 161(4):233-238. PubMed ID: 35466608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What the Oncologist Needs From the Pathologist for Immune Therapies.
    Bernicker EH
    Arch Pathol Lab Med; 2019 Dec; 143(12):1513-1516. PubMed ID: 31403333
    [No Abstract]   [Full Text] [Related]  

  • 39. Targets...targets...targets... Targeted therapies in lung cancer.
    Belani CP
    Clin Lung Cancer; 2001 May; 2(4):251. PubMed ID: 14720354
    [No Abstract]   [Full Text] [Related]  

  • 40. THE CONTRIBUTION of the pathologist to the cancer team.
    Cancer Bull; 1955; 7(2):33-4. PubMed ID: 14364488
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.